Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > ICTV Comments on the Derma Wand's Gorgeous Results

Abstract:
International Commercial Television, Inc. (OTCBB:ICTL) ("ICTV" or "The Company") a premier consumers products company employing the strength of revenue generating, prominently profiled infomercial campaigns to market and brand unique "Fountain of Youth" products to the global consumer through multi-channels of distribution including Direct Response Television ("DRTV"), retail and the internet comments on its rapid and continuing business expansion.

ICTV Comments on the Derma Wand's Gorgeous Results

BAINBRIDGE ISLAND, WA | Posted on August 22nd, 2007


The Company is pleased to report that the financial performance of the Company in the second quarter of 2007 surpassed the total revenue and net profit earned by the Company in all of 2006. Gross Revenue for 2nd Quarter 2007 was $3,151,752 versus the year end 2006 total of $2,977,074.00. 2nd Quarter 2007 net profit was $468,656.00 with a 0.04 EPS compared to 2006 year end profit of $343,536.00 with a 0.03 EPS.

Other Comparative figures are as follows.

- Revenue for the 2nd Quarter 2007 of $3,151,752.00 increased 87% from 2007 1st Quarter of $1,683,045.

- Net Profit for 2nd Quarter 2007 of $468,656.00 increased 126% from 2007 1st Quarter of $206,989.00

- 2nd Quarter 2007 Gross Revenue vs. 2nd Quarter 2006 Gross Revenue increased by 1646%

- Profit growth 2nd Quarter 2007 vs. 2nd Quarter 06 was 312%



6 Month Comparative Figures

June 30, 2007 June 30, 2006
------------- -------------

NET SALES $4,834,797 $502,573

COST OF SALES $1,296,588 $273,944
------------- -------------

GROSS PROFIT 3,538,209 228,629
------------- -------------

OPERATING
EXPENSES 2,865,774 466,100
------------- -------------


OPERATING INCOME (LOSS) 672,435 (237,471)

NET INCOME (LOSS) $675,645 $(239,283)
------------- -------------
------------- -------------

NET INCOME PER SHARE $0.06 $(0.02)
------------- -------------
------------- -------------



The rapid revenue growth targets the Company has achieved is based on the Derma Wand, the Company's first "Fountain of Youth" product, and its velocity of sales increasing in its primary distribution channel of direct response television ("DRTV"). The Company is now commencing rapid expansion of its multi-distribution strategy for the Derma Wand. Along with the recent addition of the Cell-RX skincare line and other unique health and beauty products now being accepted by the Company's international customer base, ICTV is now positioned for accelerated revenue and profit growth.

Mr. Claney CEO of ICTV stated "This record 2nd Quarter is a result of an initial strong demand for our innovative product driven by a profitable DRTV campaign." Mr. Claney continues "I truly believe ICTV will make rapid and substantial progress by selling an effective Health and Beauty product blend along with the branding power of profitable DRTV campaigns which will power all forms of traditional product distribution."

####

About International Commercial Television, Inc.
Headquartered in Bainbridge Island Washington, International Commercial Television, Inc. is a rapidly expanding global consumer products company marketing unique and effective "Fountain of Youth" products with distribution channels in place in over 35 countries worldwide. The Company utilizes a distinctive marketing strategy and multi-channel distribution model to develop, market and sell health and beauty products under its Derma Wand and DermaVital Skincare brands. Marketing and distribution of the Company's products through infomercials, live home shopping television, mass retailers, spas and salons, online shopping and various other forms of distribution.

About the Derma Wand

The Company-owned Derma Wand is a highly effective, patented and unique in-home skin care appliance that helps reduce the appearance of fine lines and wrinkles, and assists in cosmetically improving overall skin appearance.

About Cell RX

The Company has acquired the worldwide rights through a license agreement to "Cell RX" skincare system from Smart Skincare Inc. The key ingredient of Cell RX is Nano-C Powder which uses a patented nanotechnology to preserve the potency of nature's most powerful anti-oxidant and collagen builder - Vitamin C. Nano-C starts as a powder but when applied to the skin's surface it becomes a cream which is instantly absorbed right into the skin and thereby most effectively employing the dynamic skin rejuvenating properties of Nano-C powder.

About the DermaVitál Skincare Line

ICTV's DermaVitál Skin Care range has been specially formulated to enhance the effectiveness of the results achieved by using the Derma Wand. The lead product in the range is the DermaVitál Hydra-Infusion Treatment and Hydrating Skin Mist, a formula that received a U.S. patent for effectively allowing water to be absorbed into skin.

Forward-Looking Statements

The matters discussed in this press release may contain "Forward-Looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995). The Company relies on the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, apply to Forward-looking statements made by ICTV. You should not place undue reliance on Forward-looking statements. These Forward-looking statements involve risks and uncertainties. The actual results that ICTV achieves may differ materially from any forward-looking statements due to such risks and uncertainties.

For more information, please click here

Contacts:
ICTV's Investor Relations Department
1-888-449-ICTV (4288)

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Financial Reports

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014

Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014

Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014

Personal Care

Good vibrations: Using light-heated water to deliver drugs - Researchers use near-infrared light to warm water-infused polymeric particles April 1st, 2014

Iranian Food Industry Utilizes Lipid Nanocarriers for Beta-Carotene Enrichment January 23rd, 2014

ASTM International Nanotechnology Committee Approves Airborne Nanoparticle Measurement Standard December 10th, 2013

Antibacterial Nanocomposites Produced from Offset Lithography Inks December 1st, 2013

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE